Back to Search
Start Over
[Dissection of differences and similarities of botanical drugs in European Union, US and Canada].
- Source :
-
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica [Zhongguo Zhong Yao Za Zhi] 2011 Oct; Vol. 36 (19), pp. 2747-50. - Publication Year :
- 2011
-
Abstract
- Because of the unique nature and treatment concept of traditional Chinese medicines (TCMs), TCMs have been respected again since 70s of last century. The regulatory agencies of some developed countries (the FDA, EMA and Health Canada etc) have published new guidance/guidelines/directives in recent years, such as the botanical drug product guidance of the FDA, the evidence for quality of finished natural health products guidance of the Health Canada and the guideline on quality of herbal medicinal products/ traditional herbal medicinal products of the EMA etc. All of the regulatory agencies are willing to scientifically evaluate the herbal medicines and accept it as therapeutic product. This paper analyzed the history of herbal medicine regulation and the similarities and differences of the regulatory requirements of the European Union, the United States and Canada, proposed possible future direction of the international development of Chinese medicine from the perspective of global regulatory affairs.
- Subjects :
- Canada
Drug and Narcotic Control history
European Union organization & administration
Herbal Medicine history
History, 20th Century
History, 21st Century
Humans
Phytotherapy standards
Plants, Medicinal chemistry
United States
Drug and Narcotic Control organization & administration
Herbal Medicine legislation & jurisprudence
Herbal Medicine organization & administration
Subjects
Details
- Language :
- Chinese
- ISSN :
- 1001-5302
- Volume :
- 36
- Issue :
- 19
- Database :
- MEDLINE
- Journal :
- Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica
- Publication Type :
- Academic Journal
- Accession number :
- 22242441